Molecular Modeling Approach to Understanding the Mode of Action ofl-Nucleosides as Antiviral Agents
Authors:
Open Access
- 1 January 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (1) , 138-144
Abstract
A series of unnaturall-nucleosides such as 3TC, FTC andl-FMAU have been found to be potent antiviral agents. The mode of action ofl-nucleosides has been found to be similar to that ofd-nucleosides as antiviral agents, despite their unnatural stereochemistry, that is, nucleotide formation by kinases followed by interaction with the reverse transcriptase (RT) of HIV or DNA polymerase. To date, the mode of action of nucleoside inhibitors at the molecular level with respect to the active conformations of the 5′-triphosphates as well as the interaction with the RT is not known. Recently, the X-ray crystal structure of the RT-DNA-dTTP catalytic complex has been reported. Computer modeling has been performed for several pairs ofd- andl-nucleoside inhibitors using the HIV-1 RT model and crystal coordinate data from a subset of the protein surrounding the deoxynucleoside triphosphate (dNTP) binding pocket region. Results from our modeling studies ofd-/l-zidovudine,d-/l-3TC,d-/l-dideoxycytosine triphosphates, dTTP and dCTP show that their binding energies correlate with the reported 50% effective concentrations. Modeling results are also discussed with respect to favorable conformations of each inhibitor at the dNTP site in the polymerization process. Additionally, the clinically important M184V mutation, which confers resistance against 3TC and FTC, was studied with our modeling system. The binding energy patterns of nucleoside inhibitors at the M184V mutation site correlate with the reported antiviral data.Keywords
This publication has 46 references indexed in Scilit:
- Mechanistic Studies Comparing the Incorporation of (+) and (−) Isomers of 3TCTP by HIV-1 Reverse TranscriptaseBiochemistry, 1998
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Lack of stereospecificity of some cellular and viral enzymes involved in the synthesis of deoxyribonucleotides and DNA: Molecular basis for the antiviral activity of unnatural l-β-nucleosidesBiochimie, 1995
- DidanosineDrugs, 1992
- Synthesis of L-3'-azido-3'-deoxythymidine (L-AZT) and its stereoisomersThe Journal of Organic Chemistry, 1991
- Solid-state conformation of anti-human immunodeficiency virus type-1 agents: Crystal structures of three 3'-azido-3'-deoxythymidine analogsJournal of the American Chemical Society, 1988
- Unusual structural features of 2′,3′-dideoxycytidine, an inhibitor of the HIV (AIDS) virusBiochemical and Biophysical Research Communications, 1988
- PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)The Lancet, 1988
- Structure and conformation of 3′-azido-3′-deoxythymidine (AZT), an inhibitor of the HIV (AIDS) virusCanadian Journal of Chemistry, 1987
- A new force field for molecular mechanical simulation of nucleic acids and proteinsJournal of the American Chemical Society, 1984